ECSP22046595A - Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina - Google Patents

Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina

Info

Publication number
ECSP22046595A
ECSP22046595A ECSENADI202246595A ECDI202246595A ECSP22046595A EC SP22046595 A ECSP22046595 A EC SP22046595A EC SENADI202246595 A ECSENADI202246595 A EC SENADI202246595A EC DI202246595 A ECDI202246595 A EC DI202246595A EC SP22046595 A ECSP22046595 A EC SP22046595A
Authority
EC
Ecuador
Prior art keywords
preparation
ilmethanamine
oxetan
processes
salt
Prior art date
Application number
ECSENADI202246595A
Other languages
English (en)
Inventor
Kevin Paul Cole
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP22046595A publication Critical patent/ECSP22046595A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un proceso e intermediario para la preparaci?n de un compuesto de f?rmula I: o una sal del mismo.
ECSENADI202246595A 2019-12-10 2022-06-10 Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina ECSP22046595A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962946146P 2019-12-10 2019-12-10

Publications (1)

Publication Number Publication Date
ECSP22046595A true ECSP22046595A (es) 2022-07-29

Family

ID=74003942

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202246595A ECSP22046595A (es) 2019-12-10 2022-06-10 Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina

Country Status (28)

Country Link
US (1) US12473267B2 (es)
EP (1) EP4073051B1 (es)
JP (1) JP7292517B2 (es)
KR (1) KR102635237B1 (es)
CN (1) CN114728923B (es)
AU (1) AU2020401539B2 (es)
CL (1) CL2022001511A1 (es)
CO (1) CO2022008127A2 (es)
DK (1) DK4073051T3 (es)
EC (1) ECSP22046595A (es)
ES (1) ES2975599T3 (es)
FI (1) FI4073051T3 (es)
HR (1) HRP20240343T1 (es)
HU (1) HUE067201T2 (es)
IL (1) IL292707B2 (es)
LT (1) LT4073051T (es)
MA (1) MA58104B1 (es)
MD (1) MD4073051T2 (es)
MX (1) MX2022006984A (es)
PE (1) PE20230183A1 (es)
PH (1) PH12022551403A1 (es)
PL (1) PL4073051T3 (es)
PT (1) PT4073051T (es)
RS (1) RS65238B1 (es)
SI (1) SI4073051T1 (es)
UA (1) UA127884C2 (es)
WO (1) WO2021118906A1 (es)
ZA (1) ZA202205170B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102635237B1 (ko) 2019-12-10 2024-02-13 일라이 릴리 앤드 캄파니 옥세탄-2-일메탄아민의 제조를 위한 방법 및 중간체
CN116217522B (zh) * 2023-02-22 2025-06-24 广东莱佛士制药技术有限公司 Glp-1受体激动剂关键中间体的手性纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208140B2 (en) * 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives
GEP20156397B (en) * 2011-05-06 2015-11-10 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Process for the preparation of a rivaroxaban and intermediates formed in said process
EP2847177B1 (en) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methods for making oxetan-3-ylmethanamines
KR102314286B1 (ko) * 2016-12-16 2021-10-21 화이자 인코포레이티드 Glp-1 수용체 작용제 및 이의 용도
US10934279B2 (en) 2018-06-13 2021-03-02 Pfizer Inc. GLP-1 receptor agonists and uses thereof
DK3806855T5 (da) 2018-06-15 2023-05-22 Pfizer GLP-1-receptoragonister og anvendelser deraf
CN109265389B (zh) 2018-08-31 2020-08-18 南京富润凯德生物医药有限公司 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法
KR102635237B1 (ko) 2019-12-10 2024-02-13 일라이 릴리 앤드 캄파니 옥세탄-2-일메탄아민의 제조를 위한 방법 및 중간체

Also Published As

Publication number Publication date
US12473267B2 (en) 2025-11-18
CL2022001511A1 (es) 2023-01-20
MX2022006984A (es) 2022-07-13
WO2021118906A1 (en) 2021-06-17
US20230013840A1 (en) 2023-01-19
MA58104B1 (fr) 2024-05-31
FI4073051T3 (fi) 2024-03-28
IL292707B1 (en) 2025-01-01
HUE067201T2 (hu) 2024-10-28
EP4073051B1 (en) 2024-02-07
AU2020401539A1 (en) 2022-06-16
IL292707A (en) 2022-07-01
NZ788612A (en) 2025-08-29
EP4073051A1 (en) 2022-10-19
HRP20240343T1 (hr) 2024-05-24
CA3160419A1 (en) 2021-06-17
CN114728923B (zh) 2024-12-24
ES2975599T3 (es) 2024-07-09
ZA202205170B (en) 2024-09-25
AU2020401539B2 (en) 2023-06-01
JP7292517B2 (ja) 2023-06-16
KR20220097941A (ko) 2022-07-08
LT4073051T (lt) 2024-03-12
CO2022008127A2 (es) 2022-06-10
RS65238B1 (sr) 2024-03-29
KR102635237B1 (ko) 2024-02-13
DK4073051T3 (da) 2024-02-26
JP2023504581A (ja) 2023-02-03
SI4073051T1 (sl) 2024-04-30
BR112022008892A2 (pt) 2022-08-23
PH12022551403A1 (en) 2023-10-09
IL292707B2 (en) 2025-05-01
PE20230183A1 (es) 2023-02-01
UA127884C2 (uk) 2024-01-31
MD4073051T2 (ro) 2024-08-31
PL4073051T3 (pl) 2024-05-20
CN114728923A (zh) 2022-07-08
PT4073051T (pt) 2024-02-21

Similar Documents

Publication Publication Date Title
CO2020014586A2 (es) Compuestos
CO2022002637A2 (es) Proceso de fabricación de moduladores de cftr
CO2020000527A2 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
AR111304A1 (es) Métodos para sintetizar un inhibidor de mcl-1
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
MX380394B (es) Compuesto novedoso de bifenilo o una sal del mismo.
ECSP17054980A (es) Inhibidores selectivos de bace1
CO2020012574A2 (es) Método para la preparación de una 1,2,4-triazolona 2,4,5-trisustituida
CO2018007008A2 (es) "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo"
CL2019000857A1 (es) Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas.
CO2019008110A2 (es) Activador de nrf2
MX2024008671A (es) Metodos de tratamiento de infecciones micobacterianas usando compuestos de tetraciclina.
CY1123406T1 (el) Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας
MX2025003091A (es) Metodo para producir derivado de heterociclideno acetamida
ECSP22046595A (es) Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina
MX2022005522A (es) Formas de sal de un receptor de componente c5a de complemento.
EA201990238A1 (ru) ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC
EA202190989A1 (ru) Новый способ синтеза производных пиперазинил-этокси-бромфенила и их применение в получении содержащих их соединений
UA127754U (uk) Поліетергуанідингідрохлорид як бактерицидна речовина
AR113783A1 (es) Compuestos moduladores de cftr, métodos para preparar formas cristalinas, y composiciones farmacéuticas
AR115865A2 (es) Compuestos terapéuticos
AR114477A1 (es) Método para la preparación de una 1,2,4-triazolona 2,4,5-trisustituida
UA127755U (uk) Поліетергуанідингідрохлорид як бактерицидна речовина